CAIRO--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue ...

MOBILE, Ala. (WKRG) — An Infirmary Health doctor is the first person to perform a TriClip G4 procedure in Mobile successfully and one of the first to perform it in the region, News 5 has learned.

Surgical bioprosthetic aortic valves made with bioengineered Resilia tissue (Edwards Lifesciences) appear to suffer less structural deterioration over 8 years compared with similar devices made of ...

Researchers have created a new noninvasive technique for performing a type of artery bypass that may change the future of ...

University of Iowa Health Care recently debuted a new, minimally invasive heart valve procedure after years of research and months of work toward approval by the Federal Drug Administration. A second ...